Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 48660* | 2017 |
Identification and characterization of metabolically benign obesity in humans N Stefan, K Kantartzis, J Machann, F Schick, C Thamer, K Rittig, ... Archives of internal medicine 168 (15), 1609-1616, 2008 | 1329 | 2008 |
Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach A Floegel, N Stefan, Z Yu, K Mühlenbruch, D Drogan, HG Joost, A Fritsche, ... Diabetes 62 (2), 639-648, 2013 | 1009 | 2013 |
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance NF Schwenzer, F Springer, C Schraml, N Stefan, J Machann, F Schick Journal of hepatology 51 (3), 433-445, 2009 | 931 | 2009 |
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes B Vozarova, N Stefan, RS Lindsay, A Saremi, RE Pratley, C Bogardus, ... diabetes 51 (6), 1889-1895, 2002 | 931 | 2002 |
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications N Stefan, HU Häring, FB Hu, MB Schulze The lancet Diabetes & endocrinology 1 (2), 152-162, 2013 | 884 | 2013 |
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body … N Stefan, B Vozarova, T Funahashi, Y Matsuzawa, C Weyer, RS Lindsay, ... Diabetes 51 (6), 1884-1888, 2002 | 805 | 2002 |
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies N Stefan, HU Häring, K Cusi The lancet Diabetes & endocrinology 7 (4), 313-324, 2019 | 764 | 2019 |
Causes and metabolic consequences of fatty liver N Stefan, K Kantartzis, HU Häring Endocrine reviews 29 (7), 939-960, 2008 | 727 | 2008 |
Obesity and impaired metabolic health in patients with COVID-19 N Stefan, AL Birkenfeld, MB Schulze, DS Ludwig Nature Reviews Endocrinology 16 (7), 341-342, 2020 | 710 | 2020 |
α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans N Stefan, AM Hennige, H Staiger, J Machann, F Schick, SM Kröber, ... Diabetes care 29 (4), 853-857, 2006 | 696 | 2006 |
The role of hepatokines in metabolism N Stefan, HU Häring Nature Reviews Endocrinology 9 (3), 144-152, 2013 | 576 | 2013 |
Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans N Stefan, F Schick, HU Häring Cell metabolism 26 (2), 292-300, 2017 | 504 | 2017 |
Plasma fetuin-A levels and the risk of type 2 diabetes N Stefan, A Fritsche, C Weikert, H Boeing, HG Joost, HU Häring, ... Diabetes 57 (10), 2762-2767, 2008 | 481 | 2008 |
Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans C Pfannenberg, MK Werner, S Ripkens, I Stef, A Deckert, M Schmadl, ... Diabetes 59 (7), 1789-1793, 2010 | 465 | 2010 |
Adiponectin-its role in metabolism and beyond N Stefan, M Stumvoll Hormone and Metabolic Research 34 (09), 469-474, 2002 | 450 | 2002 |
Global pandemics interconnected—obesity, impaired metabolic health and COVID-19 N Stefan, AL Birkenfeld, MB Schulze Nature Reviews Endocrinology 17 (3), 135-149, 2021 | 432 | 2021 |
Plasma adiponectin concentrations in children: relationships with obesity and insulinemia N Stefan, JC Bunt, AD Salbe, T Funahashi, Y Matsuzawa, PA Tataranni The Journal of Clinical Endocrinology & Metabolism 87 (10), 4652-4656, 2002 | 419 | 2002 |
Causes, consequences, and treatment of metabolically unhealthy fat distribution N Stefan The lancet Diabetes & endocrinology 8 (7), 616-627, 2020 | 398 | 2020 |
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms SA Schäfer, O Tschritter, F Machicao, C Thamer, N Stefan, B Gallwitz, ... Diabetologia 50, 2443-2450, 2007 | 394 | 2007 |